🇺🇸 FDA
Patent

US 8796302

Methods related to the treatment of neurodegenerative and inflammatory conditions

granted A61KA61K31/19A61K31/46

Quick answer

US patent 8796302 (Methods related to the treatment of neurodegenerative and inflammatory conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/19, A61K31/46, A61K31/485, A61K38/06